Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Brain repair, especially axonal sprouting, is critical to restore motor function in disabled stroke patients. Liraglutide (LG) is a new kind of long‐acting analogue of glucagon‐like peptide‐1 (GLP‐1) and has potential protective effects in stroke. The mitochondria participate in brain repair after cerebral injury. However, the mechanism of the effect of LG on brain repair and its potential influence on mitochondria in stroke remains obscure. Here, in focal cerebral cortical ischemic mice model, LG improved the motor functional recovery and promoted axonal sprouting by restoring the activities of isocitrate dehydrogenase, α‐ketoglutarate dehydrogenase, and succinate dehydrogenase. Moreover, LG remarkably increased the cell survival rate and revived the NeuN and GAP‐43 levels in cortical neurons under hydrogen peroxide (H 2 O 2) exposure. It was also observed that LG reduced the generation of reactive oxygen species, stabilized the mitochondrial membrane potential, enhanced the levels of adenosine triphosphate, enhanced activities of mitochondrial complex‐I, and decreased protein expression levels of fission‐1 in H 2 O 2‐injured cortical neurons. Additionally, LG suppressed the expressions of sirtuin 1 (Sirt1) in cortical neurons exposed to H 2 O 2. Furthermore, knockdown of Sirt1 by short interfering RNA facilitated the LG‐mediated mitochondrial protection in cortical neurons under H 2 O 2. Collectively, this data from the present study illustrated that LG exerted a promoting influence on brain repair, after cerebral ischemic injury, through Sirt1‐mediated mitochondrial improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., Sugimoto, T., Haneda, M., Kashiwagi, A., & Koya, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41376 · Cited by 640 · cited 1×
“Studies implicated that impaired autophagic function could be related to decreased activity of Sirt1 under redundant oxidative stress (Kume et al., 2010).”
BackgroundAthauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · cited 1×
“A large number of studies have demonstrated the neuroprotective effects of GLP‐1 analogue on central nervous system diseases, including stroke, Parkinson’s disease, and Alzheimer’s disease (Athauda & Foltynie, 2016; Calsolaro & Edison, 2015; C. H. Lee et al., 2011).”
BackgroundHernández, C., Bogdanov, P., Corraliza, L., García-Ramírez, M., Solà-Adell, C., Arranz, J. A., Arroba, A. I., Valverde, A. M., & Simó, R. (2016) · Diabetes · doi:10.2337/db15-0443 · Cited by 267 · cited 1×
“LG is a human incretin GLP‐1 analogue that has been clinically used for lowering high blood glucose (Drucker et al., 2010) and can cross the blood–brain barrier in the brains of mouse models of Alzheimer disease (Hernández et al., 2016).”
MethodMarosi, K., Kim, S. W., Moehl, K., Scheibye‐Knudsen, M., Cheng, A., Cutler, R., Camandola, S., & Mattson, M. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13868 · Cited by 242 · cited 1×
“The mitochondria may play a vital role in brain repair, including neurite outgrowth and axonal remodeling (Cheng et al., 2010; Mattson, 2007).”
BackgroundDrucker, D. J., Dritselis, A., & Kirkpatrick, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3148 · Cited by 181
Calsolaro, V., & Edison, P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0301-8 · Cited by 93 · cited 1×
“A large number of studies have demonstrated the neuroprotective effects of GLP‐1 analogue on central nervous system diseases, including stroke, Parkinson’s disease, and Alzheimer’s disease (Athauda & Foltynie, 2016; Calsolaro & Edison, 2015; C. H. Lee et al., 2011).”
BackgroundChen, Y., Zhang, X., He, J., Xie, Y., & Yang, Y. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.12.015 · Cited by 32
Cited by
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 302
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases
Jiao, F., & Gong, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6782872 · Cited by 288
GLP-1 receptor agonist as a modulator of innate immunity
Chen, J., Mei, A., Wei, Y., Li, C., Qian, H., Min, X., Yang, H., Dong, L., Rao, X., & Zhong, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997578 · Cited by 120
Luna-Marco, C., Iannantuoni, F., Hermo-Argibay, A., Devos, D., Salazar, J. D., Víctor, V. M., & Rovira-Llopis, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.015 · Cited by 114
Detka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79
“isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and succinate dehydrogenase, and at the same time reduced generation of reactive oxygen species stabilized the mitochondrial membrane potential, enhanced the levels of ATP, and enhanced the activity of the mitochondrial complex I [94].”
Background
Metadata
- Authors
- He, W., Wang, H., Zhao, C., Tian, X., Li, L., & Wang, H.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-09-18
- Volume
- 235
- Issue
- 3
- Pages
- 2986-3001
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2974350912
- Cited by
- 43
- References
- 9
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke. https://app.cochat.ai/papers/10.1002/jcp.29204
- The paper
- He, W., Wang, H., Zhao, C., Tian, X., Li, L., & Wang, H. (2020). Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.29204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.